Drug Shortage Report for TEVA-QUININE

Last updated on 2020-01-24 History
Report ID 95393
Drug Identification Number 00021016
Brand name TEVA-QUININE
Common or Proper name QUININE CAPS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) QUININE SULFATE
Strength(s) 300MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 500
ATC code P01BC
ATC description ANTIMALARIALS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2019-10-03
Estimated end date
Actual end date 2020-01-23
Shortage status Resolved
Updated date 2020-01-24
Company comments Pack size is discontinued.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-01-24 French Compare
v4 2020-01-24 English Compare
v3 2019-10-04 English Compare
v2 2019-10-03 French Compare
v1 2019-10-03 English Compare